Bryan McKibben

Medicinal Chemistry

Bryan McKibben has over 20 years of experience as a medicinal chemist. Bryan started his career in biotech with Cadus Pharmaceuticals which was subsequently bought by OSI Pharmaceuticals. He later joined Boehringer-Ingelheim Pharmaceuticals and worked in immunology / inflammatory drug discovery. Currently, Bryan is Project Director (Principal Scientist II) in Drug Discovery at AbbVie where he leads a team of interdisciplinary scientists. Over his career, Bryan played a key role in advancing multiple compounds into clinical trials. Bryan was trained as a synthetic organic chemist. He received a PhD with Professor Tomas Hudlicky at Virginia Tech, followed by a postdoctoral fellowship with Professor Victor Snieckus at the University of Waterloo.

More from Bryan

Join the Drug Hunter Mailing List

to get free content and resources weekly. Trusted by >8,000 drug hunters worldwide. Unsubscribe anytime.